相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis
Bo Yi Kim et al.
MOLECULAR NEUROBIOLOGY (2017)
Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277)
X-Y Qin et al.
MOLECULAR PSYCHIATRY (2017)
A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia
X-Y Qin et al.
MOLECULAR PSYCHIATRY (2017)
Specific protein biomarker patterns for Alzheimer's disease: improved diagnostics in progress
Illana Gozes
EPMA JOURNAL (2017)
Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease?
Valentina Echeverria et al.
CURRENT ALZHEIMER RESEARCH (2017)
ADNP Plays a Key Role in Autophagy: From Autism to Schizophrenia and Alzheimer's Disease
Shlomo Sragovich et al.
BIOESSAYS (2017)
Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease
David J. Braun et al.
ASN NEURO (2017)
The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease
M. Florencia Iulita et al.
CURRENT ALZHEIMER RESEARCH (2016)
Increased serum concentrations of transforming growth factor-β1 (TGF-β1) in patients with Guillain-Barre syndrome
Kuo-Hsuan Chang et al.
CLINICA CHIMICA ACTA (2016)
Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease
Scott E. Counts et al.
CURRENT ALZHEIMER RESEARCH (2016)
Circulating insulin-like growth factor 1 and insulin-like growth factor binding protein-3 level in Alzheimer's disease: a meta-analysis
Xiaohui Hu et al.
NEUROLOGICAL SCIENCES (2016)
Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease
S-S Jiao et al.
TRANSLATIONAL PSYCHIATRY (2016)
Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease
Philip P. Ostrowski et al.
PLOS ONE (2016)
Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers
Anna Malishkevich et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Cerebrospinal fluid biomarkers for Alzheimer's disease: current limitations and recent developments
Henrik Zetterberg
CURRENT OPINION IN PSYCHIATRY (2015)
Brain-derived neurotrophic factor and TrkB expression in the oldest-old, the 90+Study: correlation with cognitive status and levels of soluble amyloid-beta
Bernadeta Michalski et al.
NEUROBIOLOGY OF AGING (2015)
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease
Orestes Vicente Forlenza et al.
NEUROMOLECULAR MEDICINE (2015)
The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease
Josiane Budni et al.
AGING AND DISEASE (2015)
Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer's disease in patients with the apolipoprotein E ε4 genotype
Chao Wang et al.
BIOMARKERS (2015)
Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis
A. Masi et al.
MOLECULAR PSYCHIATRY (2015)
Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects
Orestes Vicente Forlenza et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
Miguel Medina et al.
BIOCHEMICAL PHARMACOLOGY (2014)
The Role of Neuronal Insulin/Insulin-Like Growth Factor-1 Signaling for the Pathogenesis of Alzheimer's Disease: Possible Therapeutic Implications
Johanna Zemva et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease
Mayara Chaves Faria et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis
B. S. Fernandes et al.
MOLECULAR PSYCHIATRY (2014)
Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia The Framingham Heart Study
Galit Weinstein et al.
JAMA NEUROLOGY (2014)
ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice
C. Tiveron et al.
CELL DEATH AND DIFFERENTIATION (2013)
Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track?
Zaira Esposito et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Early BDNF Treatment Ameliorates Cell Loss in the Entorhinal Cortex of APP Transgenic Mice
Alan H. Nagahara et al.
JOURNAL OF NEUROSCIENCE (2013)
proNGF Inhibits Neurogenesis and Induces Glial Activation in Adult Mouse Dentate Gyrus
Jingjing Guo et al.
NEUROCHEMICAL RESEARCH (2013)
Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer's disease and amnestic mild cognitive impairment
Li Huang et al.
NEUROSCIENCE LETTERS (2013)
The role of neurotrophins in major depressive disorder
Cheng Jiang et al.
TRANSLATIONAL NEUROSCIENCE (2013)
Hippocampal ProNGF Signaling Pathways and β-Amyloid Levels in Mild Cognitive Impairment and Alzheimer Disease
Elliott J. Mufson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease
Maria Bjorkqvist et al.
PLOS ONE (2012)
Decreased serum angiogenin level in Alzheimer's disease
Yong Nam Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients
Christoph Laske et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
Alan H. Nagahara et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease
Josef Marksteiner et al.
NEUROBIOLOGY OF AGING (2011)
INTRANASAL BRAIN-DERIVED NEUROTROPHIC FACTOR PROTECTS BRAIN FROM ISCHEMIC INSULT VIA MODULATING LOCAL INFLAMMATION IN RATS
Y. Jiang et al.
NEUROSCIENCE (2011)
Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
Rebecca Craig-Schapiro et al.
PLOS ONE (2011)
A Meta-Analysis of Cytokines in Alzheimer's Disease
Walter Swardfager et al.
BIOLOGICAL PSYCHIATRY (2010)
Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels
F. Angelucci et al.
CURRENT ALZHEIMER RESEARCH (2010)
Galanin Protects Amyloid-beta-Induced Neurotoxicity on Primary Cultured Hippocampal Neurons of Rats
Yong Cheng et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Altered NCAM Expression Associated with the Cholinergic System in Alzheimer's Disease
Barbara Aisa et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
ProNGF mediates death of Natural Killer cells through activation of the p75NTR-sortilin complex
Mary-Louise Rogers et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Brain-Derived Neurotrophic Factor Inhibits Cell Cycle Reentry but Not Endoplasmic Reticulum Stress in Cultured Neurons Following Oxidative or Excitotoxic Stress
Nadia Boutahar et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Effects of proNGF on Neuronal Viability, Neurite Growth and Amyloid-beta Metabolism
Yan-Jiang Wang et al.
NEUROTOXICITY RESEARCH (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
ProNGF induces TNFα-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway
Frederic Lebrun-Julien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Glial Cell-Line Derived Neurotrophic Factor (GDNF) Concentrations in Cerebrospinal Fluid and Serum of Patients with Early Alzheimer's Disease and Normal Controls
Guido Straten et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
New Insights in the Biology of BDNF Synthesis and Release: Implications in CNS Function
Michael E. Greenberg et al.
JOURNAL OF NEUROSCIENCE (2009)
Alzheimer's disease
Alistair Burns et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Memory loss in Alzheimer’s disease: implications for development of therapeutics
Carl A Gold et al.
Expert Review of Neurotherapeutics (2008)
Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats
S. Arancibia et al.
NEUROBIOLOGY OF DISEASE (2008)
Analysis of cerebrospinal fluid of Alzheimer patients
Josef Marksteiner et al.
PHARMACOLOGY (2008)
Measurements of brain-derived neurotrophic factor: Methodological aspects and demographical data
Viktorija Trajkovska et al.
BRAIN RESEARCH BULLETIN (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment
Martina Chiappelli et al.
REJUVENATION RESEARCH (2006)
Cerebrospinal fluid nerve growth factor levels in patients with Alzheimer's disease
Farhad Mashayekhi et al.
ANNALS OF SAUDI MEDICINE (2006)
Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways
RD Almeida et al.
CELL DEATH AND DIFFERENTIATION (2005)
The yin and yang of neurotrophin action
B Lu et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms
J Lee et al.
EXPERIMENTAL NEUROLOGY (2005)
Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease
SY Peng et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR
CE Pedraza et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Angiogenesis-inflammation cross-talk: Vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization
F Mor et al.
JOURNAL OF IMMUNOLOGY (2004)
Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease
SY Peng et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
VEGF-mediated inflammation precedes angiogenesis in adult brain
SD Croll et al.
EXPERIMENTAL NEUROLOGY (2004)
Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease
EJ Mufson et al.
ARCHIVES OF NEUROLOGY (2003)
Neurotrophins and their receptors: A convergence point for many signalling pathways
MV Chao
NATURE REVIEWS NEUROSCIENCE (2003)
Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease
B Michalski et al.
MOLECULAR BRAIN RESEARCH (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Serum nerve growth factor concentration and its role in the preclinical stage of dementia
RT Schaub et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease
M Fahnestock et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
Nerve growth factor signaling, neuroprotection, and neural repair
MV Sofroniew et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains
N Durany et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2000)
Region-specific neurotrophin imbalances in Alzheimer disease Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas
C Hock et al.
ARCHIVES OF NEUROLOGY (2000)
Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease
RMD Holsinger et al.
MOLECULAR BRAIN RESEARCH (2000)